BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17187360)

  • 1. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
    Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
    Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis.
    Pannone G; Bufo P; Serpico R; Rubini C; Zamparese R; Corsi F; Pedicillo MC; Pannone G; Staibano S; De Rosa G; Lo Muzio L
    Histol Histopathol; 2007 Nov; 22(11):1241-9. PubMed ID: 17647197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
    Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
    World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas.
    Marioni G; Bedogni A; Giacomelli L; Ferraro SM; Bertolin A; Facco E; Staffieri A; Marino F
    Acta Otolaryngol; 2005 Nov; 125(11):1218-23. PubMed ID: 16353406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
    Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
    PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.
    De Maria S; Pannone G; Bufo P; Santoro A; Serpico R; Metafora S; Rubini C; Pasquali D; Papagerakis SM; Staibano S; De Rosa G; Farina E; Emanuelli M; Santarelli A; Mariggiò MA; Lo Russo L; Lo Muzio L
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):107-16. PubMed ID: 18642030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression in oral squamous cell carcinoma.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Rubini C; Mariggiò MA; Procaccini M; Ferrari F; De Rosa G; Altieri DC
    Br J Cancer; 2003 Dec; 89(12):2244-8. PubMed ID: 14676801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
    Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
    Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
    J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.